Literature DB >> 11792833

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.

Deborah Thompson1, Csilla I Szabo, Jon Mangion, Rogier A Oldenburg, Fabrice Odefrey, Sheila Seal, Rita Barfoot, Karin Kroeze-Jansema, Dawn Teare, Nazneen Rahman, Hélène Renard, Graham Mann, John L Hopper, Saundra S Buys, Irene L Andrulis, Ruby Senie, Mary B Daly, Dee West, Elaine A Ostrander, Ken Offit, Tamar Peretz, Ana Osorio, J Benitez, Katherine L Nathanson, Olga M Sinilnikova, Edith Olàh, Yves-Jean Bignon, Pablo Ruiz, Michael D Badzioch, Hans F A Vasen, Andrew P Futreal, Catherine M Phelan, Steven A Narod, Henry T Lynch, Bruce A J Ponder, Ros A Eeles, Hanne Meijers-Heijboer, Dominique Stoppa-Lyonnet, Fergus J Couch, Diana M Eccles, D Gareth Evans, Jenny Chang-Claude, Gilbert Lenoir, Barbara L Weber, Peter Devilee, Douglas F Easton, David E Goldgar, Michael R Stratton.   

Abstract

The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial aggregation of the disease. A recent study of 77 multiple case breast cancer families from Scandinavia found evidence of linkage between the disease and polymorphic markers on chromosome 13q21. We have evaluated the contribution of this candidate "BRCA3" locus to breast cancer susceptibility in 128 high-risk breast cancer families of Western European ancestry with no identified BRCA1 or BRCA2 mutations. No evidence of linkage was found. The estimated proportion (alpha) of families linked to a susceptibility locus at D13S1308, the location estimated by Kainu et al. [(2000) Proc. Natl. Acad. Sci. USA 97, 9603-9608], was 0 (upper 95% confidence limit 0.13). Adjustment for possible bias due to selection of families on the basis of linkage evidence at BRCA2 did not materially alter this result (alpha = 0, upper 95% confidence limit 0.18). The proportion of linked families reported by Kainu et al. (0.65) is excluded with a high degree of confidence in our dataset [heterogeneity logarithm of odds (HLOD) at alpha = 0.65 was -11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer.

Entities:  

Mesh:

Year:  2002        PMID: 11792833      PMCID: PMC117390          DOI: 10.1073/pnas.012584499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.

Authors:  Y Y Shugart; C Cour; H Renard; G Lenoir; D Goldgar; D Teare; D Easton; N Rahman; R Gusterton; S Seal; R Barfoot; M Stratton; J Mangion; T Peelen; A van den Ouweland; H Meijers; P Devilee; D Eccles; H Lynch; B Weber; D Stoppa-Lyonnet; Y J Bignon; J Chang-Claude
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

2.  Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.

Authors:  C Eng; L C Brody; T M Wagner; P Devilee; J Vijg; C Szabo; S V Tavtigian; K L Nathanson; E Ostrander; T S Frank
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Authors:  T Kainu; S H Juo; R Desper; A A Schaffer; E Gillanders; E Rozenblum; D Freas-Lutz; D Weaver; D Stephan; J Bailey-Wilson; O P Kallioniemi; M Tirkkonen; K Syrjäkoski; T Kuukasjärvi; P Koivisto; R Karhu; K Holli; A Arason; G Johannesdottir; J T Bergthorsson; H Johannsdottir; V Egilsson; R B Barkardottir; O Johannsson; K Haraldsson; T Sandberg; E Holmberg; H Grönberg; H Olsson; A Borg; P Vehmanen; H Eerola; P Heikkila; S Pyrhönen; H Nevanlinna
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

6.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.

Authors:  F Kerangueven; L Essioux; A Dib; T Noguchi; F Allione; J Geneix; M Longy; R Lidereau; F Eisinger; M J Pébusque
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

8.  The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance.

Authors:  J R O'Connell; D E Weeks
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

9.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  20 in total

1.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

2.  BAP1 and breast cancer risk.

Authors:  Isabelle Coupier; Pierre-Yves Cousin; David Hughes; Patricia Legoix-Né; Alexandra Trehin; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  KIAA0101 interacts with BRCA1 and regulates centrosome number.

Authors:  Zeina Kais; Sanford H Barsky; Haritha Mathsyaraja; Alicia Zha; Derek J R Ransburgh; Gang He; Robert T Pilarski; Charles L Shapiro; Kun Huang; Jeffrey D Parvin
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

4.  Decreased expression of LMO7 and its clinicopathological significance in human lung adenocarcinoma.

Authors:  Hiroyuki Nakamura; Keiko Hori; Miki Tanaka-Okamoto; Masahiko Higashiyama; Yu Itoh; Masahiro Inoue; Setsuko Morinaka; Jun Miyoshi
Journal:  Exp Ther Med       Date:  2011-08-11       Impact factor: 2.447

Review 5.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

6.  Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.

Authors:  Juan Manuel Rosa-Rosa; Guillermo Pita; Miguel Urioste; Gemma Llort; Joan Brunet; Conxi Lázaro; Ignacio Blanco; Teresa Ramón y Cajal; Orland Díez; Miguel de la Hoya; Trinidad Caldés; Maria-Isabel Tejada; Anna González-Neira; Javier Benítez
Journal:  Am J Hum Genet       Date:  2009-01-15       Impact factor: 11.025

7.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

8.  A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer.

Authors:  Philippe Rostagno; Jeanine Gioanni; Eliane Garino; Pierre Vallino; Moise Namer; Marc Frenay
Journal:  J Hum Genet       Date:  2003-06-24       Impact factor: 3.172

Review 9.  BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Authors:  Olga M Sinilnikova; Sylvie Mazoyer; Colette Bonnardel; Henry T Lynch; Steven A Narod; Gilbert M Lenoir
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

10.  African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.

Authors:  Vanessa B Sheppard; Kristi D Graves; Juleen Christopher; Alejandra Hurtado-de-Mendoza; Costellia Talley; Karen Patricia Williams
Journal:  J Genet Couns       Date:  2013-11-05       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.